HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth Hensley Selected Research

Microtubule-Associated Proteins (Microtubule-Associated Protein 2)

8/2022Effects of Lanthionine Ketimine-5-Ethyl Ester on the α-Synucleinopathy Mouse Model.
1/2016Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.
10/2013A derivative of the brain metabolite lanthionine ketimine improves cognition and diminishes pathology in the 3 × Tg-AD mouse model of Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth Hensley Research Topics

Disease

12Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
07/2014 - 07/2002
11Alzheimer Disease (Alzheimer's Disease)
01/2018 - 04/2002
7Neuroinflammatory Diseases
08/2022 - 10/2003
7Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018 - 04/2002
5Neoplasms (Cancer)
09/2013 - 05/2002
4Stroke (Strokes)
01/2015 - 04/2002
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2011 - 03/2005
3Multiple Sclerosis
01/2022 - 07/2015
3Cognitive Dysfunction
01/2016 - 10/2013
3Glioma (Gliomas)
12/2015 - 09/2013
3Dementia (Dementias)
09/2013 - 09/2002
3Weight Loss (Weight Reduction)
11/2009 - 05/2004
3Inflammation (Inflammations)
11/2009 - 07/2002
2Parkinson Disease (Parkinson's Disease)
01/2020 - 11/2008
2Brain Injuries (Brain Injury)
01/2016 - 08/2006
2Central Nervous System Diseases (CNS Diseases)
12/2015 - 11/2008
2Motor Neuron Disease (Primary Lateral Sclerosis)
01/2015 - 08/2005
2Ischemic Stroke
09/2013 - 09/2011
2Schizophrenia (Dementia Praecox)
06/2011 - 02/2010
2Amyloid Plaque
01/2011 - 01/2010
2Autoimmune Diseases (Autoimmune Disease)
08/2006 - 03/2005
2Cardiovascular Diseases (Cardiovascular Disease)
08/2006 - 01/2004
1Synucleinopathies
08/2022
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022
1Demyelinating Diseases (Demyelinating Disease)
01/2022
1Spinal Cord Injuries (Spinal Cord Injury)
01/2017
1Cicatrix (Scar)
01/2017
1Neuroblastoma
12/2015
1Tuberous Sclerosis (Bourneville's Disease)
12/2015
1Chronic Disease (Chronic Diseases)
07/2015
1Agranulocytosis (Granulocytopenia)
02/2014
1Ischemia
02/2014
1Cardiotoxicity
02/2014
1Immune System Diseases (Immune Disorders)
02/2014
1Hypertension (High Blood Pressure)
12/2013
1Pheochromocytoma
12/2013
1Glioblastoma (Glioblastoma Multiforme)
09/2013
1Septic Shock (Toxic Shock Syndrome)
09/2013
1Infections
09/2013
1Malaria
09/2013
1Brain Ischemia (Cerebral Ischemia)
12/2012
1Epilepsy (Aura)
06/2011
1Disease Progression
11/2009

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
08/2022 - 07/2002
12lanthionine ketimineIBA
01/2022 - 06/2011
11EstersIBA
08/2022 - 09/2013
6lanthionineIBA
08/2022 - 09/2013
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009 - 07/2002
5Semaphorin-3AIBA
08/2022 - 02/2010
5CytokinesIBA
01/2010 - 07/2002
4AntioxidantsIBA
01/2022 - 08/2006
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
08/2022 - 10/2013
3Pharmaceutical PreparationsIBA
01/2016 - 06/2011
3Peptides (Polypeptides)IBA
07/2015 - 02/2010
3Free RadicalsIBA
10/2013 - 04/2002
3nitronesIBA
09/2013 - 04/2002
3AutoantibodiesIBA
07/2008 - 03/2005
3Superoxide Dismutase-1IBA
11/2006 - 07/2002
2tau Proteins (tau Protein)IBA
01/2016 - 10/2004
2Sirolimus (Rapamycin)FDA Link
01/2016 - 12/2015
2Amyloid (Amyloid Fibrils)IBA
01/2016 - 10/2013
2Antidepressive Agents (Antidepressants)IBA
12/2013 - 06/2011
2tianeptine (Stablon)IBA
12/2013 - 06/2011
2phenyl-N-tert-butylnitroneIBA
09/2013 - 04/2002
2alpha-TocopherolFDA Link
01/2011 - 01/2004
2Vitamin EFDA LinkGeneric
01/2011 - 11/2008
2gamma-TocopherolIBA
01/2011 - 01/2004
2EicosanoidsIBA
01/2010 - 01/2006
2Lenalidomide (CC 5013)FDA Link
11/2009 - 03/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2003 - 05/2002
1CuprizoneIBA
01/2022
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2020
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2018
1Okadaic AcidIBA
01/2018
1Serotonin (5 Hydroxytryptamine)IBA
01/2017
1Growth InhibitorsIBA
01/2017
1Midi-GAGRIBA
01/2016
1collapsin response mediator protein-2IBA
01/2016
1trans-sodium crocetinate (crocetin)IBA
12/2015
1Beclin-1IBA
12/2015
1Myelin-Oligodendrocyte GlycoproteinIBA
07/2015
1Neuropilin-1IBA
07/2014
1Epinephrine (Adrenaline)FDA LinkGeneric
12/2013
1Hormones (Hormone)IBA
12/2013
1Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2013
1CatecholaminesIBA
12/2013
1Chromogranin AIBA
12/2013
1Cytoplasmic DyneinsIBA
12/2013
1KetamineFDA LinkGeneric
09/2013
1Biological ProductsIBA
09/2013
1OKN 007IBA
09/2013
1disufenton sodium (NXY 059)IBA
09/2013
1SirtuinsIBA
12/2012
1LacosamideFDA Link
06/2011
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
05/2011
1dihydropyrimidinaseIBA
02/2010
1Myelin Basic ProteinIBA
02/2010
1Qa-SNARE Proteins (Syntaxin)IBA
02/2010
1Fas Ligand Protein (Fas Ligand)IBA
11/2009

Therapy/Procedure

8Therapeutics
01/2022 - 09/2002